BFA
ALIM

BlackRock Fund Advisors’s Alimera Sciences ALIM Stock Holding History

BlackRock Fund Advisors’s Portfolio ALIM Stock Details ALIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$168K Buy
10,383
+791
+8% +$14.5K ﹤0.01% 3467
2016
Q3 		$214K Buy
9,592
+3,388
+55% +$78K ﹤0.01% 3426
2016
Q2 		$114K Sell
6,204
-45,071
-88% -$1.2M ﹤0.01% 3636
2016
Q1 		$1.35M Sell
51,275
-2,972
-5% -$92.5K ﹤0.01% 3156
2015
Q4 		$1.97M Sell
54,247
-42,205
-44% -$1.83M ﹤0.01% 3154
2015
Q3 		$3.2M Buy
96,452
+7,658
+9% +$431K ﹤0.01% 2994
2015
Q2 		$6.14M Buy
88,794
+1,885
+2% +$130K ﹤0.01% 2800
2015
Q1 		$6.53M Buy
86,909
+3,602
+4% +$283K ﹤0.01% 2687
2014
Q4 		$6.92M Buy
83,307
+42,212
+103% +$3.43M ﹤0.01% 2683
2014
Q3 		$3.34M Sell
41,095
-1,618
-4% -$138K ﹤0.01% 2972
2014
Q2 		$3.83M Buy
42,713
+10,043
+31% +$892K ﹤0.01% 2977
2014
Q1 		$3.87M Buy
32,670
+1,941
+6% +$189K ﹤0.01% 2958
2013
Q4 		$2.17M Sell
30,729
-1,362
-4% -$55.5K ﹤0.01% 3133
2013
Q3 		$1.81M Buy
32,091
+3,703
+13% +$232K ﹤0.01% 3135
2013
Q2 		$2.08M Buy
+28,388
New +$1.64M ﹤0.01% 3090

Other funds holding ALIM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

BlackRock Fund Advisors's ALIM Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Alimera Sciences (ALIM) stake by 8.2% in Q4 2016, buying an estimated $14.5K and bringing the position to 10,383 shares worth $168K. The position accounts for ﹤0.01% of the portfolio, ranked #3467.

BlackRock Fund Advisors first reported a position in ALIM in Q2 2013 and has held it in 15 quarters since. The position peaked at $6.92M in Q4 2014. 47 funds tracked by Wall St. Rank hold ALIM as of Q4 2016.

  • BlackRock Fund Advisors held 10,383 shares of Alimera Sciences worth $168K as of Q4 2016.
  • BlackRock Fund Advisors bought 791 Alimera Sciences shares in Q4 2016, an estimated $14.5K.
  • Alimera Sciences made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3467 holding.
  • BlackRock Fund Advisors first reported a position in Alimera Sciences in Q2 2013 and has held it in 15 quarters since.
  • BlackRock Fund Advisors's Alimera Sciences position peaked at $6.92M in Q4 2014.
  • 47 funds tracked by Wall St. Rank held Alimera Sciences as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.